Current Gene Therapy : Impact Factor & More
eISSN: 1875-5631pISSN: 1566-5232
Share this on:
Aims and Scope of Current Gene Therapy
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
CiteScore 
5.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.89
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Gene Therapy
Current Gene Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Gene Therapy
CRISPR-Cas9: A Paradigm Shift in Gene Editing Addressing Antimicrobial Resistance.
- 6 Jan 2026
- Current gene therapy
Recent Advances on RNA-Based Molecular Therapies for Tumour Cell Targeting.
- 6 Jan 2026
- Current gene therapy
Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation.
- 25 Nov 2025
- Current gene therapy
A Comprehensive Review on Human Metapneumovirus.
- 5 Nov 2025
- Current gene therapy
Foxp3+ Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2-STAT3 Pathway in Ovarian Cancer Progression.
- 29 Oct 2025
- Current gene therapy
Attenuated Salmonella Carrying IL-21-siRNA-CCR2 Co-expression Plasmid Enhances Anti-tumor Immune Response in Lung Cancer-bearing Mice.
- 27 Oct 2025
- Current gene therapy
CRISPR-Cas9: A Paradigm Shift in Gene Editing Addressing Antimicrobial Resistance.
- 6 Jan 2026
- Current gene therapy
Recent Advances on RNA-Based Molecular Therapies for Tumour Cell Targeting.
- 6 Jan 2026
- Current gene therapy
Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation.
- 25 Nov 2025
- Current gene therapy
A Comprehensive Review on Human Metapneumovirus.
- 5 Nov 2025
- Current gene therapy
Foxp3+ Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2-STAT3 Pathway in Ovarian Cancer Progression.
- 29 Oct 2025
- Current gene therapy
Attenuated Salmonella Carrying IL-21-siRNA-CCR2 Co-expression Plasmid Enhances Anti-tumor Immune Response in Lung Cancer-bearing Mice.
- 27 Oct 2025
- Current gene therapy
FAQs on Current Gene Therapy
How long has Current Gene Therapy been actively publishing? 
What is the publishing frequency of Current Gene Therapy?
How many articles did Current Gene Therapy publish last year?
What is the eISSN & pISSN for Current Gene Therapy?
What is Citescore for Current Gene Therapy?
What is SNIP score for Current Gene Therapy?
What is the SJR for Current Gene Therapy?
Who is the publisher of Current Gene Therapy?
